Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (511-520 of 776) with videos related to

Pageof 78
Sort By:
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Neurology|April 1, 2016
Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer diseaseYen Ying Lim, Simon M Laws, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2023
Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and PlansSharon L Naismith, Johannes C Michaelian, Cherry Santos, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's DiseaseNatasha Krishnadas, Kun Huang, Stephanie A Schultz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2017
Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illnessKarra D Harrington, Yen Ying Lim, David Ames, et al.
Journal of Affective Disorders|January 13, 2018
Amyloid burden and incident depressive symptoms in preclinical Alzheimer's diseaseStephanie Perin, Karra D Harrington, Yen Ying Lim, et al.
Research Square|November 24, 2025
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Pageof 78

Showing results (511-520 of 776) with videos related to

Sort By:
Pageof 78
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Neurology|April 1, 2016
Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer diseaseYen Ying Lim, Simon M Laws, Victor L Villemagne, et al.
Journal of Alzheimer'S Disease : JAD|November 6, 2023
Tackling Dementia Together via The Australian Dementia Network (ADNeT): A Summary of Initiatives, Progress and PlansSharon L Naismith, Johannes C Michaelian, Cherry Santos, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2010
PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analysesNoel G Faux, Craig W Ritchie, Adam Gunn, et al.
Journal of Alzheimer'S Disease : JAD|July 11, 2022
Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's DiseaseNatasha Krishnadas, Kun Huang, Stephanie A Schultz, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 2, 2017
Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illnessKarra D Harrington, Yen Ying Lim, David Ames, et al.
Journal of Affective Disorders|January 13, 2018
Amyloid burden and incident depressive symptoms in preclinical Alzheimer's diseaseStephanie Perin, Karra D Harrington, Yen Ying Lim, et al.
Research Square|November 24, 2025
Predicting accumulation and age at onset of amyloid-β from genetic risk and resilience for Alzheimer's diseaseEleanor K O'Brien, Timothy Cox, Shane Fernandez, et al.
Pageof 78